Mittmann N - Search Results

1

Cost effectiveness of budesonide/formoterol added to tiotropium bromide versus placebo added to tiotropium bromide in patients with chronic obstructive pulmonary disease: Australian, Canadian and Swedish healthcare perspectives.

Mittmann N, Hernandez P, Mellström C, Brannman L, Welte T. Mittmann N, et al. Pharmacoeconomics. 2011 May;29(5):403-14. doi: 10.2165/11590380-000000000-00000. Pharmacoeconomics. 2011. PMID: 21504240

2

Sensitivity analysis in health economic and pharmacoeconomic studies. An appraisal of the literature.

Agro KE, Bradley CA, Mittmann N, Iskedjian M, Ilersich AL, Einarson TR. Agro KE, et al. Among authors: mittmann n. Pharmacoeconomics. 1997 Jan;11(1):75-88. doi: 10.2165/00019053-199711010-00009. Pharmacoeconomics. 1997. PMID: 10165529

3

Utility scores for chronic conditions in a community-dwelling population.

Mittmann N, Trakas K, Risebrough N, Liu BA. Mittmann N, et al. Pharmacoeconomics. 1999 Apr;15(4):369-76. doi: 10.2165/00019053-199915040-00004. Pharmacoeconomics. 1999. PMID: 10537955

4

Warfarin in the secondary prevention of thromboembolism in atrial fibrillation: impact of bioavailability on costs and outcomes.

Mittmann N, Oh PI, Walker SE, Bartle WR. Mittmann N, et al. Pharmacoeconomics. 2004;22(10):671-83. doi: 10.2165/00019053-200422100-00005. Pharmacoeconomics. 2004. PMID: 15244492

5

The cost of moderate and severe COPD exacerbations to the Canadian healthcare system.

Mittmann N, Kuramoto L, Seung SJ, Haddon JM, Bradley-Kennedy C, Fitzgerald JM. Mittmann N, et al. Respir Med. 2008 Mar;102(3):413-21. doi: 10.1016/j.rmed.2007.10.010. Epub 2007 Dec 20. Respir Med. 2008. PMID: 18086519 Free article.

6

Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.

Mittmann N, Au HJ, Tu D, O'Callaghan CJ, Isogai PK, Karapetis CS, Zalcberg JR, Evans WK, Moore MJ, Siddiqui J, Findlay B, Colwell B, Simes J, Gibbs P, Links M, Tebbutt NC, Jonker DJ; Working Group on Economic Analysis of National Cancer Institute of Canada Clinical Trials Group; Australasian Gastrointestinal Interest Group. Mittmann N, et al. J Natl Cancer Inst. 2009 Sep 2;101(17):1182-92. doi: 10.1093/jnci/djp232. Epub 2009 Aug 7. J Natl Cancer Inst. 2009. PMID: 19666851

7

The direct medical costs associated with suspected heparin-induced thrombocytopenia.

Nanwa N, Mittmann N, Knowles S, Bucci C, Selby R, Shear N, Walker SE, Geerts W. Nanwa N, et al. Among authors: mittmann n. Pharmacoeconomics. 2011 Jun;29(6):511-20. doi: 10.2165/11584330-000000000-00000. Pharmacoeconomics. 2011. PMID: 21473656

8

Guidelines for health technologies: specific guidance for oncology products in Canada.

Mittmann N, Evans WK, Rocchi A, Longo CJ, Au HJ, Husereau D, Leighl NB, Isogai PK, Krahn MD, Peacock S, Marshall D, Coyle D, Taylor SC, Jacobs P, Oh PI. Mittmann N, et al. Value Health. 2012 May;15(3):580-5. doi: 10.1016/j.jval.2011.12.006. Epub 2012 Feb 16. Value Health. 2012. PMID: 22583470 Free article.

9

Cost effectiveness of adding budesonide/formoterol to tiotropium in COPD in four Nordic countries.

Nielsen R, Kankaanranta H, Bjermer L, Lange P, Arnetorp S, Hedegaard M, Stenling A, Mittmann N. Nielsen R, et al. Among authors: mittmann n. Respir Med. 2013 Nov;107(11):1709-21. doi: 10.1016/j.rmed.2013.06.007. Epub 2013 Jul 13. Respir Med. 2013. PMID: 23856511 Free article. Clinical Trial.

10

Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.

Fowler RA, Mittmann N, Geerts W, Heels-Ansdell D, Gould MK, Guyatt G, Krahn M, Finfer S, Pinto R, Chan B, Ormanidhi O, Arabi Y, Qushmaq I, Rocha MG, Dodek P, McIntyre L, Hall R, Ferguson ND, Mehta S, Marshall JC, Doig CJ, Muscedere J, Jacka MJ, Klinger JR, Vlahakis N, Orford N, Seppelt I, Skrobik YK, Sud S, Cade JF, Cooper J, Cook D; Canadian Critical Care Trials Group; Australia and New Zealand Intensive Care Society Clinical Trials Group. Fowler RA, et al. Among authors: mittmann n. JAMA. 2014 Nov 26;312(20):2135-45. doi: 10.1001/jama.2014.15101. JAMA. 2014. PMID: 25362228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page